Microbial electrolysis cells (MECs) are an emerging technology capable of harvesting part of the potential chemical energy in organic compounds while producing hydrogen. One of the main obstacles in MECs is the bacterial anode, which usually contains mixed cultures. Non-exoelectrogens can act as a physical barrier by settling on the anode surface and displacing the exoelectrogenic microorganisms. Those non-exoelectrogens can also compete with the exoelectrogenic microorganisms for nutrients and reduce hydrogen production. In addition, the bacterial anode needs to withstand the shear and friction forces existing in domestic wastewater plants. In this study, a bacterial anode was encapsulated by a microfiltration membrane. The novel encapsulation technology is based on a small bioreactor platform (SBP) recently developed for achieving successful bioaugmentation in wastewater treatment plants. The 3D capsule (2.5 cm in length, 0.8 cm in diameter) physically separates the exoelectrogenic biofilm on the carbon cloth anode material from the natural microorganisms in the wastewater, while enabling the diffusion of nutrients through the capsule membrane. MECs based on the SBP anode (MEC-SBPs) and the MECs based on a nonencapsulated anode (MEC control) were fed with Geobacter medium supplied with acetate for 32 days, and then with artificial wastewater for another 46 days. The electrochemical activity, chemical oxygen demand (COD), bacterial anode viability and relative distribution on the MEC-SBP anode were compared with the MEC control. When the MECs were fed with artificial wastewater, the MEC-SBP produced (at −0.6 V) 1.70 ± 0.22 A m⁻², twice that of the MEC control. The hydrogen evolution rates were 0.017 and 0.005 m³ m⁻³ day⁻¹, respectively. The COD consumption rate for both was about the same at 650 ± 70 mg L⁻¹. We assume that developing the encapsulated bacterial anode using the SBP technology will help overcome the problem of contamination by non-exoelectrogenic bacteria, as well as the shear and friction forces in wastewater plants.

In this study, we present an innovative new bio-treatment approach for 17α-ethynyestradiol (EE2). Our solution for EE2 decontamination was accomplished by using the SBP (Small Bioreactor Platform) macro-encapsulation method for the encapsulation of two bacterial cultures, Rhodococcus zopfii (R. zopfii ) and Pseudomonas putida F1 (P. putida). Our results show that the encapsulated R. zopffi presented better biodegradation capabilities than P. putida F1. After 24 h of incubation on minimal medium supplemented with EE2 as a sole carbon source, EE2 biodegradation efficacy was 73.8% and 86.5% in the presence of encapsulated P. putida and R. zopfii, respectively. In the presence of additional carbon sources, EE2 biodegradation efficacy was 75% and 56.1% by R. zopfii and P. putida, respectively, indicating that the presence of other viable carbon sources might slightly reduce the EE2 biodegradation efficiency. Nevertheless, in domestic secondary effluents, EE2 biodegradation efficacy was similar to the minimal medium, indicating good adaptation of the encapsulated cultures to sanitary effluents and lack of a significant effect of the presence of other viable carbon sources on the EE2 biodegradation by the two encapsulated cultures. Our findings demonstrate that SBP-encapsulated R. zopfii and P. putida might present a practical treatment for steroidal hormones removal in wastewater treatment processes.

The bioaugmentation treatment approach presents both an economical and environmentally friendly solution for wastewater treatment. However, the use of exogenous bacterial cultures presents several limitations: negative interaction between microorganisms and adaptation to new physical and chemical composite environment. These selective forces create a significant challenge for the introduced culture to achieving the required biomass in order to conduct the target biological treatment. Small-bioreactor platform (SBP) technology is aimed at introducing exogenous bacterial culture with some protection to reduce some of the natural selection process. The current study was aimed at validating the use of SBP technology to improve biological treatment, especially during a stress period, by using macro-encapsulated bioaugmentation treatment. The study results indicate that the use of SBP technology elevates the stability of biological treatment, improving operational factors such as the reduction of foaming phenomena and sludge accumulation. Still, a significant study needs to be conducted to understand the potential of this technology; especially the impact on biological treatment by using different types of microorganisms for different types of wastewaters and the relationship between the biomass within the SBP capsules and the natural microorganisms.

A successful attempt to degrade synthetic estrogen 17α-ethynylestradiol (EE2) is demonstrated via combining photocatalysis employing magnesium peroxide (MgO₂)/low-pressure ultraviolet (LP-UV) treatment followed by biological treatment using small bioreactor platform (SBP) capsules. Reusable MgO₂ was synthesized through wet chemical synthesis and extensively characterized by X-ray diffraction (XRD) for phase confirmation, X-ray photoelectron spectroscopy (XPS) for elemental composition, Brunauer-Emmett-Teller (BET) to explain a specific surface area, scanning electron microscopy (SEM) imaging surface morphology, and UV-visible (Vis) spectrophotometry. The degradation mechanism of EE2 by MgO₂/LP-UV consisted of LP-UV photolysis of H₂O₂ in situ (produced by the catalyst under ambient conditions) to generate hydroxyl radicals, and the degradation extent depended on both MgO₂ and UV dose. Moreover, the catalyst was successfully reusable for the removal of EE2. Photocatalytic treatment by MgO₂ alone required 60 min (~1700 mJ/cm²) to remove 99% of the EE2, whereas biodegradation by SBP capsules alone required 24 h to remove 86% of the EE2, and complete removal was not reached. The sequential treatment of photocatalysis and SBP biodegradation to achieve complete removal required only 25 min of UV (~700 mJ/cm²) and 4 h of biodegradation (instead of >24 h). The combination of UV photocatalysis and biodegradation produced a greater level of EE2 degradation at a lower LP-UV dose and at less biodegradation time than either treatment used separately, proving that synergetic photocatalysis and biodegradation are effective treatments for degrading EE2.